May 07, 2018 - Bvf Inc Buys Ironwood Pharmaceuticals Inc, Merus NV, Xencor Inc, Sells Array BioPharma Inc, CytomX Therapeutics Inc, AnaptysBio Inc, Stocks: CRVS,IMDZ,PIRS,FWP,VSTM,PTGX,IRWD,MRUS,XNCR,RCUS,A, release date:May 07, 2018
May 07, 2018 - The M&A theme appears set to continue in the spotlight this year, with Gilead to put cash to work and Takeda likely to come to terms with Shire.President Trump´s drug pricing speech is expected soon a
May 06, 2018 - The stock has performed admirably since my initial article. However, it´s currently the biggest loser in the Core Biotech model account. I provide a recap of the bullish thesis and recent developments
May 04, 2018 - Match Group's (MTCH) first-quarter 2018 earnings to benefit from steady market traction of apps like Tinder, which are driving higher subscriber growth.
May 04, 2018 - Inovio's (INO) most advanced pipeline candidate, VGX-3100's progress remains in focus. However, lack of an approved product in the company's portfolio is a dampener.
May 04, 2018 - Penumbra (PEN) deepens its focus on driving innovation, ramping up production and expanding geographies.
May 04, 2018 - Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.
May 03, 2018 - With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on its immuno-oncology pipeline.
May 03, 2018 - With no approved product in Geron's (GERN) portfolio, investor focus continues to remain on its sole pipeline candidate, imetelstat, ahead of the first-quarter earnings release.
May 03, 2018 - We will initiate coverage on seven biotechnology stocks.These seven companies are primarily picked for their current valuation, pipeline prospects, financial figures, and likelihood of near-term share